• Skip to primary navigation
  • Skip to main content
Drug Hunter - discover together

Drug Hunter

Sign Up for our newsletter
  • Molecules
  • Resources
  • Articles
  • Events
  • Career Listings
  • Find Partners
    • Drug Discovery CROs
    • Drug Development CDMOs
    • Drug Discovery Products
    • Drug Discovery Equipment
    • Drug Discovery Companies
    • Drug Discovery Investors
  • Premium
  • About Us
  • Advisory Board
  • Our Reviewers
  • Our Team
  • Sponsors
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Advertise
  • Blog
  • LinkedIn
  • twitter

© Rosalind Scientific LLC 2018-2022

  • Molecules
  • Resources
  • Articles
  • Events
  • Career Listings
  • Find Partners
    • Drug Discovery CROs
    • Drug Development CDMOs
    • Drug Discovery Products
    • Drug Discovery Equipment
    • Drug Discovery Companies
    • Drug Discovery Investors
  • Premium
Subscribe Log in
  • LinkedIn
  • twitter

New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >4,000 drug hunters worldwide, unsubscribe anytime.

Consent(Required)
(Required)
Subscribe Log in

imatinib sales

  • Cover photo for Drug Hunter article "The Post-Gleevec Era"

    The Post-Gleevec Era

    Gleevec (imatinib) was the first tyrosine kinase inhibitor approved for the treatment of cancer and one of the first products to emerge from “rational drug design.”  It’s invention changed chronic myeloid leukemia from an incurable death sentence to a manageable disease. Here’s a look back on the tremendous value it’s created over the last two…

Sign Up for our newsletter
  • Molecules
  • Resources
  • Articles
  • Events
  • Career Listings
  • Find Partners
    • Drug Discovery CROs
    • Drug Development CDMOs
    • Drug Discovery Products
    • Drug Discovery Equipment
    • Drug Discovery Companies
    • Drug Discovery Investors
  • Premium
  • About Us
  • Advisory Board
  • Our Reviewers
  • Our Team
  • Sponsors
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • Advertise
  • Blog
  • LinkedIn
  • twitter

© Rosalind Scientific LLC 2018-2022